FindTrial
Sign In

Clinical Analysis of 8 Acquired Hepatocerebral Degeneration Cases

Clinical Analysis of 8 Acquired Hepatocerebral Degeneration Cases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300072238
Enrollment
Unknown
Registered
2023-06-07
Start date
2023-05-02
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acquired Hepatocerebral Degeneration

Interventions

Case series:N/A

Sponsors

Dalian Municiple Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
66 Years to 89 Years

Inclusion criteria

Inclusion criteria: 1) History of decompensated liver cirrhosis or portosystemic shunt. (2) Recurring HE. (3) The main manifestation is brain function damage caused by extrapyramidal symptoms. (4) Head MRI examination showed symmetrical T1 weighted high signal intensity in the basal ganglia area. (5) Excluding other types of encephalopathy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Neurological manifestations;—

Secondary

MeasureTime frame
Presence of hepatic encephalopathy;—

Countries

China

Contacts

Public ContactTongdan Tang

Dalian Municiple Center Hospital

tangtongdan2002@sina.com+86 199 6931 0647

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026